arcadia

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE2631.9520 (+0.77 %)
PREV CLOSE ( ) 2611.95
OPEN PRICE ( ) 2610.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2631.95 (1)
VOLUME 8319
TODAY'S LOW / HIGH ( )2603.00 2641.10
52 WK LOW / HIGH ( )2033 2965.2
NSE2632.5019.35 (+0.74 %)
PREV CLOSE( ) 2613.15
OPEN PRICE ( ) 2619.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2632.50 (123)
VOLUME 349052
TODAY'S LOW / HIGH( ) 2600.20 2642.00
52 WK LOW / HIGH ( )1872.95 2964
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
22Jul IFCI, IOL Chemicals & Pharmaceuticals
IFCI is expecting to mobilise Rs 1,500-2,000 crore from sale of non-core..
22Jul Dr. Reddy’s Lab trades in green on the
Dr. Reddy’s Lab is currently trading at Rs. 2640.00, up by 26.05 points..
20Jul Dr. Reddy's Lab completes divestment o
Dr. Reddy's Laboratories has closed the transaction with Upsher-Smith La..
19Jul Dr Reddy's Lab launches Fexofenadine H
Dr. Reddy's Laboratories has launched Fexofenadine HCI 60 mg and Pseudoe..
19Jul Dr. Reddy’s Laboratories informs about
Dr. Reddy’s Laboratories has informed about Press Release on 'Dr. Reddy'..
Financials
Rs. in Millions
QTR Mar 19 ANNUAL 19
Net Profit202812773
Gross Profit 2964 17007
Operating Profit 509325381
Net Sales 26452106255
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Aurobindo Pharma (BSE)
 570.30 (3.26%)
M.Cap ( in Cr)33414.77
Medicamen Biotech (BSE)
 419.55 (2.73%)
M.Cap ( in Cr)512.55
Glaxosmithkline Phar (BSE)
 1182.65 (0.78%)
M.Cap ( in Cr)20034.80
Lupin (BSE)
 755.85 (1.17%)
M.Cap ( in Cr)34209.07
Wintac (BSE)
 192.90 (4.72%)
M.Cap ( in Cr)193.37
Shareholding Pattern
PROMOTERS 26.76%
NON-INSTITUTION 14.44%
MUTUAL FUNDS/UTI 8.57%
FI/BANKS/INSURANCE 5.14%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM